BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11727328)

  • 41. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving drug safety using computational biology.
    Cook D
    IDrugs; 2010 Feb; 13(2):85-9. PubMed ID: 20127559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of data mining approaches to drug delivery.
    Ekins S; Shimada J; Chang C
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1409-30. PubMed ID: 17081647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current directions in the evolution of compound libraries.
    Webb TR
    Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective.
    Manly CJ; Chandrasekhar J; Ochterski JW; Hammer JD; Warfield BB
    Drug Discov Today; 2008 Feb; 13(3-4):99-109. PubMed ID: 18275907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-throughput electronic biology: mining information for drug discovery.
    Loging W; Harland L; Williams-Jones B
    Nat Rev Drug Discov; 2007 Mar; 6(3):220-30. PubMed ID: 17330071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
    Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
    Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advanced exact structure searching in large databases of chemical compounds.
    Trepalin SV; Skorenko AV; Balakin KV; Nasonov AF; Lang SA; Ivashchenko AA; Savchuk NP
    J Chem Inf Comput Sci; 2003; 43(3):852-60. PubMed ID: 12767143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive toxicology: benchmarking molecular descriptors and statistical methods.
    Feng J; Lurati L; Ouyang H; Robinson T; Wang Y; Yuan S; Young SS
    J Chem Inf Comput Sci; 2003; 43(5):1463-70. PubMed ID: 14502479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Development of research support environment for molecular pharmacology and toxicology].
    Kaminuma T; Nakata K; Nakano T; Takai T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2000; (118):117-22. PubMed ID: 11534110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure activity relationship in toxicology.
    Vereczkey L
    Acta Physiol Hung; 1995; 83(1):47-50. PubMed ID: 7660836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Architecture of the drug-drug interaction network.
    Hu TM; Hayton WL
    J Clin Pharm Ther; 2011 Apr; 36(2):135-43. PubMed ID: 21366641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.